# Vidatalk Communication Application: Usability, Acceptability and Efficacy Study

> **NCT02921776** · NA · COMPLETED · sponsor: **Ohio State University** · enrollment: 147 (actual)

## Conditions studied

- Nonverbal Communication
- Critical Illness

## Interventions

- **OTHER:** Aim 1 - VidaTalk - post-extubation
- **OTHER:** Aim 2 - VidaTalk - intubated
- **DEVICE:** Aim 3 - VidaTalk tablet app
- **OTHER:** Aim 3 - attention-control with non-VidaTalk tablet

## Key facts

- **NCT ID:** NCT02921776
- **Lead sponsor:** Ohio State University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-02-19
- **Primary completion:** 2019-06-11
- **Final completion:** 2019-06-11
- **Target enrollment:** 147 (ACTUAL)
- **Last updated:** 2022-03-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02921776

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02921776, "Vidatalk Communication Application: Usability, Acceptability and Efficacy Study". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT02921776. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*